Our Board of Directors

Chair, Medical Oncologist

Headshot of Mark Shackleton Chairman of Melanoma and Skin Cancer Trials

Professor Shackleton is Director of Oncology at Alfred Health, Professor of Oncology at Monash University, Director of Cancer Trials Australia, and a Victorian Cancer Agency Clinical Research Fellow. After training in medical oncology in Melbourne, he undertook PhD studies at the Walter and Eliza Hall Institute and post-doctoral work at the University of Michigan, receiving several major prizes including the 2012 Australian Science Minister’s Prize for Life Scientist of the Year.

Deputy Chair, Surgical Oncologist

Headshot of Andrew Spillane Deputy Chair of Melanoma and Skin Cancer Trials

Andrew Spillane is Professor of Surgical Oncology at the University of Sydney. He is appointed to the Northern Clinical School, Mater and Royal North Shore Hospitals. He is a Faculty Member of Melanoma Institute Australia. He is former President of BreastSurgANZ, Breast Craft Group Lead for BCT, breast disease section editor for ANZ Journal of Surgery and skin oncology editorial board member for Annals of Surgical Oncology and Journal of Surgical Oncology.


Headshot of Victoria Mar Director of Melanoma and Skin Cancer Trials

A/Prof. Victoria Mar is a Fellow of the Australasian College of Dermatologists and Director of the Victorian Melanoma Service at the Alfred Hospital. She is an NHMRC Early Career Fellow at the School of Public Health and Preventive Medicine, Monash University. She has an interest in early diagnosis and surveillance of high-risk individuals and has authored and co-authored a number of chapters for the Cancer Council Australia Melanoma Guidelines and is Clinical Lead for the Melanoma Clinical Outcomes Registry.

Company Secretary, Patient Advocate

Headshot of Paul White Director of Melanoma and Skin Cancer Trials

Mr White is a Fellow of the Institute of Chartered Accountants in Australia and a Certified Internal Auditor. He has 20 years’ experience in assurance and business consulting across NGOs, government departments and large listed companies, and is a leader in risk management. Paul is also a melanoma survivor and is the immediate past-Chair of the Australian Melanoma Consumer Alliance and the Melbourne Melanoma Consumer Reference Group.

Surgical Oncologist

Headshot of Richard Martin Director of Melanoma and Skin Cancer Trials

Richard chairs the National Melanoma Standards group for the Ministry of Health plus the Auckland Regional Melanoma Multidisciplinary meeting and sits on the executive committees of MELNET and Melanoma New Zealand charity. He is also a Senior Lecturer at the University of Auckland, publishes in numerous academic journals, is a regular presenter at national and international conferences and is actively involved in research and clinical trials.


Headshot of Peter Soyer Director of Melanoma and Skin Cancer Trials

Professor Soyer is the Director of the Dermatology Research Centre, The University of Queensland Diamantina Institute and the Princess Alexandra Hospital Dermatology Department. He leads the NHMRC Centre of Research Excellence for the Study of Naevi and the ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis. He has a MRFF Practitioner Fellowship and is a Fellow of the Australian Academy of Health and Medical Sciences.

Cancer Epidemiologist

Professor Michael Kimlin is an internationally renowned leader in cancer research and cancer control. He is trained as a Cancer Epidemiologist and has significant experience and leadership of, and research into, cancer aetiology, risk and control. He has received over $27M in competitive research funding, has more than 215 journal publications, and has a proven track record of undertaking large, multidisciplinary cancer research programs.


Mary Tsouvalakis is a Managing Principal Solicitor, Corporate Legal Advisory at the Victorian Department of Health. Her legal experience spans across two decades advising private and public sector clients on all aspects of commercial law and commercial litigation, with a focus on the provision of legal advice to the health and medical sector. Mary brings to the Board considerable knowledge and experience in government legal frameworks and governance. She also brings to the Board a lived experience with cancer, including skin cancer.